Cardiac Resynchronization Therapy Devices (CRT)

Cardiac Resynchronization Therapy Devices (CRT) are cardiac electrophysiology (EP) systems that include a small electronic device that is surgically implanted into a pocket of skin to help both ventricles contract together. They are also called biventricular pacemakers. These systems can be used for pacing only, or can include a built-in defibrillator.

ENHANCE CRT Pilot Study Evaluates Alternative Approach for Non-Left Bundle Branch Block Patients
News | Leads Implantable Devices | May 18, 2018
May 18, 2018 — Data on the effectiveness of cardiac resynchronization therapy (CRT) in patients with non-left bundle...
Cardiac Contractility Modulation Safe and Effective as Heart Failure Treatment

Image courtesy of Impulse Dynamics

News | Heart Failure | May 18, 2018
May 18, 2018 — In a new study, cardiac contractility modulation (CCM) therapy was confirmed to significantly improve...
Heart Rhythm Society (HRS) live electrophysiology (EP) procedure case at the 2018 annual meeting. #HRS2018

A live EP case presentation during the 2018 Heart Rhythm meeting.

Feature | HRS | May 18, 2018 | Dave Fornell
Here is an aggregation of all the news and late-breaking studies presented at the 2018 Heart Rhythm Society (HRS)...
LivaNova Completes Sale of Cardiac Rhythm Management (CRM - electrophysiology) Business to MicroPort Scientific
News | EP Lab | April 30, 2018
April 30, 2018 — LivaNova announced it completed the sale of its cardiac rhythm management (CRM) business to MicroPort...
Biotronik U.S. to Distribute Aziyo ECM Envelopes
News | Implantable Cardioverter Defibrillator (ICD) | April 12, 2018
April 12, 2018 — Biotronik U.S. and Aziyo announced a strategic agreement allowing Biotronik to distribute Aziyo's...
Medtronic Recalls CRT-Ds and ICDs Due to Manufacturing Error Preventing Electrical Shock Delivery
News | Cardiac Resynchronization Therapy Devices (CRT) | February 26, 2018
February 26, 2018 — The U.S. Food and Drug Administration (FDA) announced that Medtronic is recalling certain...
Abbott Announces MR-Conditional Labeling for Quadra Assura CRT-D and Fortify Assura ICD
Technology | Cardiac Resynchronization Therapy Devices (CRT) | January 03, 2018
January 3, 2018 — Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-...
Research team (left to right) Abdul Wase M.D. (principal ivestigator), Marina Brown R.N., Ken Shneider, Thein Aung M.D., Matt Clark, Dawn Hunt and Kimberle Evans R.N., with a Tesla car at Good Samaritan Hospital Dayton, Ohio.  Image courtesy of Joe Carfora.

Research team (left to right) Abdul Wase M.D. (principal ivestigator), Marina Brown R.N., Ken Shneider, Thein Aung M.D., Matt Clark, Dawn Hunt and Kimberle Evans R.N., with a Tesla car at Good Samaritan Hospital Dayton, Ohio. 
Image courtesy of Joe Carfora.

News | November 25, 2017
November 25, 2017 — Sitting in, or standing close to the charging port of a Tesla electric vehicle did not trigger a...
Trial Data Shows Positive Predictive Results for Boston Scientific HeartLogic Heart Failure Diagnostic
News | Heart Failure | October 20, 2017
October 20, 2017 — Boston Scientific announced new data from the Multisensor Chronic Evaluation in Ambulatory Heart...
Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD) | September 27, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of implantable cardioverter defibrillator...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab | September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global electrophysiology...
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT) | August 21, 2017
August 21, 2017 — Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of...
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT) | July 21, 2017
July 21, 2017 — Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX...
Biotronik Hosts Heart Failure Symposium at Europace-Cardiostim 2017
News | Heart Failure | July 13, 2017
July 13, 2017 — Experts in heart failure management gathered in June to discuss varying scientific evidence in their...
New Data Reveal Medtronic CRT Devices Improve Therapy Delivery and Reduce Healthcare Costs
News | Cardiac Resynchronization Therapy Devices (CRT) | July 06, 2017
July 6, 2017 — New data showed use of Medtronic’s cardiac resynchronization therapy (CRT) devices with its proprietary...